We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

A Multitude of Choice in Antimicrobial Screening

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Antimicrobial Array I tests for sulphonamides, Array II for general antibiotics and Array III for nitrofurans, chloramphenicol and malachite green.

These antimicrobials are extensively used in human and veterinary medicine and their use in food producing animals could result in potentially harmful concentrations in tissue, organs and milk. This can lead to allergies for example to sulphonamide drugs which are relatively common and include skin rash, hives and anaphylaxis. Maximum residue limits have been set for the majority of these anti-microbial agents therefore screening on a regular basis is imperative.

Randox revolutionary biochip array technology is based on established ELISA principles utilising competitive chemiluminescent immunoassays. The biochip contains an array of immobilised antibodies each specific to a different antimicrobial. With as little as 50µl of urine or one gram of tissue, the antimicrobial analytes on each array can be analysed concurrently. The antimicrobial arrays are analysed on the semi-automated Evidence Investigator generating 540 tests in less than two hours. These arrays all provide excellent sensitivity, precision and recovery.